Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis
Thymosin α1 is used in the clinic as a treatment in viral disease and acts as an anti-inflammatory. Here it was found to also correct the misfolding of mutant CTFR and potentiate its activity, thus improving outcome in a mouse model of cystic fibrosis. Cystic fibrosis (CF) is caused by mutations in...
Saved in:
Published in | Nature Medicine Vol. 23; no. 5; pp. 590 - 600 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article Magazine Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.05.2017
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!